InvestorsHub Logo
Followers 107
Posts 16648
Boards Moderated 0
Alias Born 06/24/2014

Re: None

Thursday, 05/30/2024 3:03:52 PM

Thursday, May 30, 2024 3:03:52 PM

Post# of 203
Ivonescimab Monotherapy Decisively Beats Pembrolizumab Monotherapy Head-to-Head, Achieves Statistically Significant Superiority in PFS in First-Line Treatment of Patients with PD-L1 Positive NSCLC in China
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SMMT News